Cargando…
The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
BACKGROUND: The treatment of migraine is impeded by several difficulties, among which insufficient headache relief, side effects, and risk for developing medication overuse headache (MOH). Thus, new acutely acting antimigraine drugs are currently being developed, among which the small molecule CGRP...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734450/ https://www.ncbi.nlm.nih.gov/pubmed/31096904 http://dx.doi.org/10.1186/s10194-019-1007-y |